Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

NCT01078974 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Safety concerns (IgM Flare)

Conditions

Waldenstrom's Macroglobulinemia

Interventions

DRUG: pomalidomide
DRUG: dexamethasone
DRUG: rituximab

Sponsor

Steven P. Treon, MD, PhD

Collaborators

[object Object]